Published in Pharmacol Ther on June 15, 2011
Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav Immun (2014) 1.44
The influence of maternal prenatal and early childhood nutrition and maternal prenatal stress on offspring immune system development and neurodevelopmental disorders. Front Neurosci (2013) 0.99
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98
Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98
Neural circuitry and immunity. Immunol Res (2015) 0.97
Viral infection, inflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry (2015) 0.90
DISC1 Pathway in Brain Development: Exploring Therapeutic Targets for Major Psychiatric Disorders. Front Psychiatry (2012) 0.90
The role of inflammation in schizophrenia. Front Neurosci (2015) 0.89
Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [(18)F]FEPPA. Am J Psychiatry (2016) 0.85
Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives. Clin Dev Immunol (2013) 0.85
Toll-like receptor-2 deficiency induces schizophrenia-like behaviors in mice. Sci Rep (2015) 0.85
Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel) (2014) 0.84
Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: An In-Vivo PET Study with [(18)F]FEPPA. Neuropsychopharmacology (2017) 0.84
Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation. Mol Med (2015) 0.82
Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis. PLoS One (2014) 0.82
Elevated levels of circulating IL-18BP and perturbed regulation of IL-18 in schizophrenia. J Neuroinflammation (2012) 0.81
Peripheral endocannabinoid system dysregulation in first-episode psychosis. Neuropsychopharmacology (2013) 0.81
Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. J Clin Psychopharmacol (2015) 0.80
Evidence for an immune role on cognition in schizophrenia: a systematic review. Curr Neuropharmacol (2014) 0.80
Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat. Psychopharmacology (Berl) (2012) 0.79
Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry (2017) 0.78
Hippocampal volume and depressive symptoms are linked to serum IL-18 in schizophrenia. Neurol Neuroimmunol Neuroinflamm (2015) 0.77
Paliperidone prevents brain toll-like receptor 4 pathway activation and neuroinflammation in rat models of acute and chronic restraint stress. Int J Neuropsychopharmacol (2014) 0.77
The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry (2016) 0.77
Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. PLoS Med (2016) 0.77
Greater extracellular free-water in first-episode psychosis predicts better neurocognitive functioning. Mol Psychiatry (2017) 0.76
Pro-/antiinflammatory dysregulation in early psychosis: results from a 1-year follow-up study. Int J Neuropsychopharmacol (2014) 0.76
Inflammatory Cytokines and Antipsychotic-Induced Weight Gain: Review and Clinical Implications. Mol Neuropsychiatry (2016) 0.75
Cryoglobulins as potential triggers of inflammation in schizophrenia. Schizophr Res Treatment (2013) 0.75
Simvastatin augmentation for recent-onset psychotic disorder: A study protocol. BBA Clin (2015) 0.75
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model. Neuropsychopharmacology (2017) 0.75
Antigliadin Antibodies (AGA IgG) Are Related to Neurochemistry in Schizophrenia. Front Psychiatry (2017) 0.75
Schizophrenia symptomatic associations with diffusion tensor imaging measured fractional anisotropy of brain: a meta-analysis. Neuroradiology (2017) 0.75
Neuroimmune Interactions in Schizophrenia: Focus on Vagus Nerve Stimulation and Activation of the Alpha-7 Nicotinic Acetylcholine Receptor. Front Immunol (2017) 0.75
Psychoneuroimmunoendocrinology: clinical implications. World Allergy Organ J (2017) 0.75
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Non-linearity and frequency shifts of nuclear magnetic spin-noise. J Magn Reson (2009) 1.37
Public stigma against people with mental illness in the Gilgel Gibe Field Research Center (GGFRC) in Southwest Ethiopia. PLoS One (2013) 1.36
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry (2002) 1.28
The identification of free-living environmental isolates of amoebae from Bulgaria. Parasitol Res (2004) 1.27
Developmental neuroinflammation and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2011) 1.26
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
An ancestral secretory apparatus in the protozoan parasite Giardia intestinalis. J Biol Chem (2003) 1.23
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res (2010) 1.22
Immune System and Schizophrenia. Curr Immunol Rev (2010) 1.18
Signal enhancement in protein NMR using the spin-noise tuning optimum. J Biomol NMR (2010) 1.18
Support of the histaminergic hypothesis in Tourette syndrome: association of the histamine decarboxylase gene in a large sample of families. J Med Genet (2013) 1.16
Neuropsychiatric disorders related to interferon and interleukins treatment. Metab Brain Dis (2008) 1.13
Substance P serum levels are increased in major depression: preliminary results. Biol Psychiatry (2003) 1.08
Interleukin-6-deficient mice are highly susceptible to Giardia lamblia infection but exhibit normal intestinal immunoglobulin A responses against the parasite. Infect Immun (2003) 1.07
Observation of NMR noise from solid samples. J Magn Reson (2010) 1.07
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
Serodiagnosis of Echinococcus spp. infection: explorative selection of diagnostic antigens by peptide microarray. PLoS Negl Trop Dis (2010) 1.07
A novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides. Antimicrob Agents Chemother (2007) 1.06
Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease. Int J Alzheimers Dis (2010) 1.05
Assessment of Echinococcus granulosus somatic protoscolex antigens for serological follow-up of young patients surgically treated for cystic echinococcosis. J Clin Microbiol (2008) 1.05
In vitro effects of thiazolides on Giardia lamblia WB clone C6 cultured axenically and in coculture with Caco2 cells. Antimicrob Agents Chemother (2006) 1.05
Electroconvulsive therapy in a patient with Tourette's syndrome and co-morbid Obsessive Compulsive Disorder. World J Biol Psychiatry (2004) 1.04
Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders. Expert Rev Neurother (2006) 1.02
A psychoneuroimmunological perspective to Emil Kraepelins dichotomy: schizophrenia and major depression as inflammatory CNS disorders. Eur Arch Psychiatry Clin Neurosci (2008) 1.01
Isolation and molecular characterization of recombinant Echinococcus granulosus P29 protein (recP29) and its assessment for the post-surgical serological follow-up of human cystic echinococcosis in young patients. Trans R Soc Trop Med Hyg (2008) 1.01
Intestinal Tritrichomonas foetus infection in cats in Switzerland detected by in vitro cultivation and PCR. Parasitol Res (2008) 0.98
Health-related quality of life in patients with Gilles de la Tourette's syndrome. Mov Disord (2010) 0.98
Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp Parasitol (2003) 0.98
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res (2003) 0.98
Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole. J Antimicrob Chemother (2007) 0.98
Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. Int J Parasitol (2002) 0.97
Tritrichomonas foetus isolates from cats and cattle show minor genetic differences in unrelated loci ITS-2 and EF-1α. Vet Parasitol (2011) 0.97
Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole. J Antimicrob Chemother (2008) 0.97
Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol (2003) 0.97
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. Eur Arch Psychiatry Clin Neurosci (2005) 0.97
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics. Eur Arch Psychiatry Clin Neurosci (2008) 0.96
Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.96
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother (2011) 0.96
In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infect Immun (2004) 0.96
Screening of Swiss hot spring resorts for potentially pathogenic free-living amoebae. Exp Parasitol (2009) 0.95
PCR-based diagnosis of Naegleria sp. infection in formalin-fixed and paraffin-embedded brain sections. J Clin Microbiol (2006) 0.95
Ammonium ylides for the diastereoselective synthesis of glycidic amides. Chem Commun (Camb) (2010) 0.95
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur Arch Psychiatry Clin Neurosci (2004) 0.95
The association of infectious agents and schizophrenia. World J Biol Psychiatry (2010) 0.94
The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma. Clin Cancer Res (2006) 0.94
Detection of Leishmania RNA virus in Leishmania parasites. PLoS Negl Trop Dis (2013) 0.93
COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des (2008) 0.93
Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res (2006) 0.93
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia. Eur Arch Psychiatry Clin Neurosci (2007) 0.92
Inflammatory biomarkers and depression. Neurotox Res (2010) 0.92
Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2004) 0.92
Spin-Noise-Detected Two-Dimensional Fourier-Transform NMR Spectroscopy. J Phys Chem Lett (2013) 0.92
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.92
Non-linear signal detection improvement by radiation damping in single-pulse NMR spectra. Chemphyschem (2012) 0.92
Comparative study on the antioxidant and biological activities of carvacrol, thymol, and eugenol derivatives. J Agric Food Chem (2008) 0.92
In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrob Agents Chemother (2005) 0.91
Design, synthesis, and application of tartaric acid derived N-spiro quaternary ammonium salts as chiral phase-transfer catalysts. Org Biomol Chem (2011) 0.91
Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull (2013) 0.91
The first observation of Carbon-13 spin noise spectra. J Magn Reson (2012) 0.91
Long-term results of electroconvulsive therapy in severe Gilles de la Tourette syndrome. J ECT (2011) 0.91
The role of B- and T-cell immunity in toltrazuril-treated C57BL/6 WT, microMT and nude mice experimentally infected with Neospora caninum. Parasitol Res (2004) 0.90
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatment. Dialogues Clin Neurosci (2009) 0.90
Anti-inflammatory treatment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.89
Asymmetric syntheses of three-membered heterocycles using chiral amide-based ammonium ylides. Org Biomol Chem (2015) 0.89
Interpreting conformational effects in protein nano-ESI-MS spectra. Anal Bioanal Chem (2003) 0.89
Hepatic gene expression profile in mice perorally infected with Echinococcus multilocularis eggs. PLoS One (2010) 0.88
Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry (2005) 0.88
Cost of illness in patients with Gilles de la Tourette's syndrome. J Neurol (2010) 0.88
On the tuning of high-resolution NMR probes. Chemphyschem (2014) 0.87
Quetiapine in the treatment of schizophrenia and related disorders. Neuropsychiatr Dis Treat (2007) 0.87
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J Psychiatr Res (2008) 0.87
Metabolism of nitro drugs metronidazole and nitazoxanide in Giardia lamblia: characterization of a novel nitroreductase (GlNR2). J Antimicrob Chemother (2013) 0.87
Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene. Brain Behav Immun (2013) 0.87
Therapy-refractory Tourette syndrome: beneficial outcome with globus pallidus internus deep brain stimulation. Mov Disord (2008) 0.87
Inflammation in schizophrenia. Adv Protein Chem Struct Biol (2012) 0.87
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma. J Immunother (2007) 0.86
Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int J Parasitol (2006) 0.86
Apparatus for rapid adjustment of the degree of alignment of NMR samples in aqueous media: verification with residual quadrupolar splittings in (23)Na and (133)Cs spectra. J Magn Reson (2006) 0.86
Functional outcome and quality of life in Tourette's syndrome after deep brain stimulation of the posteroventrolateral globus pallidus internus: long-term follow-up. World J Biol Psychiatry (2013) 0.86
S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance. Cardiovasc Psychiatry Neurol (2010) 0.86
Impaired monocyte activation in schizophrenia. Psychiatry Res (2012) 0.86
Cytomegalovirus and schizophrenia. CNS Drugs (2006) 0.86
Intraperitoneal Echinococcus multilocularis infection in mice modulates peritoneal CD4+ and CD8+ regulatory T cell development. Parasitol Int (2010) 0.86
Effects of antidepressants and cyclooxygenase-2 inhibitor on cytokines and kynurenines in stimulated in vitro blood culture from depressed patients. Inflammopharmacology (2012) 0.86
Proisocrinins A-F, brominated anthraquinone pigments from the stalked crinoid Proisocrinus ruberrimus. J Nat Prod (2009) 0.86
Intracellular monocytic cytokine levels in schizophrenia show an alteration of IL-6. Eur Arch Psychiatry Clin Neurosci (2012) 0.85
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects. Curr Pharm Des (2011) 0.85
Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. Exp Parasitol (2007) 0.85
Prenatal immunologic predictors of postpartum depressive symptoms: a prospective study for potential diagnostic markers. Eur Arch Psychiatry Clin Neurosci (2014) 0.85
Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin. Microbiology (2007) 0.85
Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis (2007) 0.85
Echinococcus multilocularis phosphoglucose isomerase (EmPGI): a glycolytic enzyme involved in metacestode growth and parasite-host cell interactions. Int J Parasitol (2010) 0.85
The role of the kynurenine metabolism in major depression. J Neural Transm (Vienna) (2011) 0.85
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha. Brain Behav Immun (2004) 0.85